It is a chemicals private limited company based in Muambi, Maharashtra, India, established in 2005.
2005 | Muambi, Maharashtra, India | Struck OffNatext Biotech Private Limited, a struck off private limited company, was established on 03 November 2005 in Muambi, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24234MH2005PTC156487. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.78 M.
It upholds a compliant status. Its leadership includes Pallavi Nilesh Doshi (Director), Rikin Doshi Nilesh (Director). Past directors included Nilesh Khushalchand Doshi, Pallavi Nilesh Doshi, Ranjan Mohan Mogre. Its latest AGM occurred on 30 September 2018, with the balance sheet filed on 31 March 2018. It is based at 6 Maheshwar Niwas44/45 Tilak Rd Santacruz (W), Muambi, Maharashtra, 400054.
U24234MH2005PTC156487
156487
03 November 2005
₹5.00 M
₹0.78 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Natext Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pallavi Nilesh Doshi | Director | 31 Jul 2013 | Current |
| Rikin Doshi Nilesh | Director | 05 Jan 2008 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Aug 2013 | Past |
| Pramod Abcsdd | Additional Director | 11 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 01 Aug 2011 | Past |
| Pramod Abcsdd | Director | 05 Jan 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Natext Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Natext Biotech had a promoter holding of 86.96% and a public holding of 13.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Natext Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Natext Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natext Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Natext Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2018 as per latest MCA records. was recorded as a recent event.
Progress on Natext Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Mumbai. was documented.
Progress on Pallavi Nilesh Doshi was appointed as a Director was appointed as a Director on 31 Jul 2013 & has been associated with this company since 12 years 4 months . was documented.
Rikin Doshi Nilesh was appointed as a Director was appointed as a Director on 05 Jan 2008 & has been associated with this company since 17 years 11 months . was recorded as a recent event.
Progress on Natext Biotech Private Limited was registered on 03 Nov 2005 with Roc Mumbai & aged 20 years 1 month as per MCA records. was documented.
The CIN of Natext Biotech Private Limited is U24234MH2005PTC156487.
Natext Biotech Private Limited is headquartered at 6 Maheshwar Niwas44/45 Tilak Rd Santacruz (W), Muambi, Maharashtra, 400054.
Natext Biotech Private Limited was incorporated on 03 November 2005.
The current directors of Natext Biotech Private Limited are
The primary industry of Natext Biotech Private Limited is Chemicals.
Natext Biotech Private Limited is unlisted.
The authorized capital of Natext Biotech Private Limited is ₹5.00 M, and the paid-up capital is ₹0.78 M.
The compliance status of Natext Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX